BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare I&I: Primary Sclerosing Cholangitis (PSC) Market Spotlight

Retail Price: $2,995.00

*BioMedTracker Subscriber Price: $2,095.00 - click here to log in

June 27, 2018

Primary sclerosing cholangitis (PSC) is a progressive, rare, and chronic cholestatic liver disorder that is characterized by thickening, inflammation, and fibrosis of the bile ducts. Both intra- and extra-hepatic bile ducts are affected. This generally leads to cholestasis, liver cirrhosis, and eventually liver failure.

This Datamonitor Healthcare report contains a Market Spotlight module.

Disease Group Covered: Autoimmune/immunology
Back to the top Back to the top